secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001213900-25-004714
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical enters $15M at-the-market equity offering with Roth Capital
-------------------------------------------------------------------------

- ATM agreement with Roth Capital Partners for up to $15M of Class A common stock.
- Sales agent compensation is 3.0% of gross proceeds; $50K expense cap.
- Shares sold at market prices; no minimum obligation to sell.
- Offering made under effective S-3 registration filed Oct 2024.
- Company may suspend sales at any time; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025004714/0001213900-25-004714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025004714/ea0228064-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-004714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer